Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, 52-Week Extension Study to Evaluate the Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia

NCT01331109 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01331109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01331109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, 52-Week Extension Study to Evaluate the Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Lead sponsor
Forest Laboratories
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2011
Completion date
August 31, 2012
Enrollment
57 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

primary fibromyalgia